Senna S Orange Tablet
NDC Package 72476-883-60

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Senna S Orange (docusate sodium sennosides) tablets is take preferably at bedtime or as directed by a doctor agestarting dosage maximum dosage adults and children 12 years of age or over2 tablets once a day4 tablets twice a day children 6 to under 12 years1 tablet once a day2 tablets twice a day children 2 to under 6 years1/2 tablet once a day 1 tablet twice a day children under 2 yearsask a doctor ask a doctor . This formulation utilizes a tablet delivery system. Marketed by Care One (retail Business Services, Llc.), this product is identified by NDC 72476-883 and is authorized under FDA application 505G(a)(3).

Identification & Billing

NDC Package Code
72476-883-60
Package Description
1 BOTTLE, PLASTIC in 1 BOX / 60 TABLET in 1 BOTTLE, PLASTIC
Product Code
72476-883
11-Digit Billing Format
72476088360
RxNorm Crosswalk
  • RxCUI: 998740 - sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet
  • RxCUI: 998740 - docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet
  • RxCUI: 998740 - DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet

Clinical Specifications

Proprietary Name
Senna S Orange
Non-Proprietary Name
Docusate Sodium Sennosides
Substance Name
Docusate Sodium; Sennosides
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Take preferably at bedtime or as directed by a doctor agestarting dosage maximum dosage adults and children 12 years of age or over2 tablets once a day4 tablets twice a day children 6 to under 12 years1 tablet once a day2 tablets twice a day children 2 to under 6 years1/2 tablet once a day 1 tablet twice a day children under 2 yearsask a doctor ask a doctor 

Regulatory & Marketing

Labeler Name
Care One (retail Business Services, Llc.)
Product Type
Human Otc Drug
FDA Application #
505G(a)(3)
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
09-30-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72476-883-60 identifies a specific commercial package of 1 bottle, plastic in 1 box / 60 tablet in 1 bottle, plastic of Senna S Orange, a human over the counter drug labeled by Care One (retail Business Services, Llc.). This tablet is formulated for oral use and contains docusate sodium; sennosides as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Care One (retail Business Services, Llc.) on September 30, 2019. The current certification is valid through December 31, 2026.

How is this Care One (retail Business Services, Llc.) product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72476088360. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72476-883-60
11-Digit CMS (5-4-2)
72476-0883-60

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.